Moscow: The third stage of the research on the world's first registered vaccine against the novel coronavirus, called Sputnik V, may begin in 7-10 days, a report has said.
According to the Tass news agency, several tens of thousands of people are expected to take part in this research of the vaccine created by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology of the Russian health ministry.
"On Monday, we will present the first version of the protocol on post-registration research," Alexander Gintsburg, Director of the Gamaleya National Research Center, was quoted as saying to Tass.
"Given this great interest and attention of the public and the press, I think that the Health Ministry won't delay the process and will approve the protocol within a week. So, I believe within seven or ten days at maximum everything will begin," Gintsburg added.
Read more:Putin's daughter receives dose of world's first COVID-19 vaccine
Gintsburg said several tens of thousands of people were expected to be involved by the third stage. The research will be conducted in the Moscow Region.